MedPath
TGA Approval

ENTRESTO 49/51 sacubitril/valsartan (combined as a sodium salt hydrate complex) 48.6/51.4 mg film-coated tablet blister pack (234222)

234222

ENTRESTO 49/51 sacubitril/valsartan (combined as a sodium salt hydrate complex) 48.6/51.4 mg film-coated tablet blister pack

Novartis Pharmaceuticals Australia Pty Ltd

January 20, 2016

Medicine

Medicine

Active

Registered

Product Information

Consumer Medicine Information

https://medical-cdn.nocode.com/drug_tga/ec8304339556f5b32b24226bfc7396f8.pdf

Product Information

https://medical-cdn.nocode.com/drug_tga/be11164d16197d71c230065e85dd9e1f.pdf

Active Ingredients

sacubitril

valsartan

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

ENTRESTO 49/51 sacubitril/valsartan (combined as a sodium salt hydrate complex) 48.6/51.4 mg film-coated tablet blister pack (234222) - TGA 批准文号 | MedPath